Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 30 ... study was to investigate the promoter methylation and expression of E-cadherin gene in gastric cardiac adenocarcinoma (GCA)." "A nested MSP approach, ... For additional information, contact Z. Dong, Hebei Medical University, Hospital 4, Hebei Cancer Institute, Dept. of Laboratory Pathology, Jiankanglu 12, Shijiazhuang 050011, Hebei, ...
2009 NOV 30 ... discuss in 'LTA 252GG and GA genotypes are associated with diffuse-type noncardia gastric cancer risk in the Japanese population' new findings in...
2009 NOV 30 ... maintenance and is believed to be crucial in most cancer cells, but its significance in gastric cancer remains unknown. This observational study investigated whether there is a relationship ...
2009 NOV 30 ... results from the report, 'Serum levels of leptin as marker for patients at high risk of gastric cancer,' have been published. "Serological screening for...
2009 NOV 30 ... or YM022 combined with H. pylori eradication therapy to prevent H. pylori-associated gastric cancer in male INS-GAS mice." "Treatments started at 22 WPI, and mice were ...
2009 NOV 30 ... biomarkers present in Barrett's oesophagus but absent from normal oesophagus and gastric mucosa. Validation was performed by qPCR (n = 10 each of normal oesophagus, Barrett's ... For additional information, contact R.C. Fitzgerald, Hutchison MRC Research Center, MRC Cancer Cell Unit, Hills Rd., Cambridge CB22 0XZ, UK. Publisher contact information ...
2009 NOV 30 ... IGF2 and H19 LOI analyses respectively. The positive rate of LIT1, IGF2 and H19 LOI of gastric cancer tissues were 54.6% (12/22), 45% (18/40) and 8.6% (3/32) in Chinese patients. Gastric ...
2009 NOV 30 ... "To evaluate clinicopathological predictors of recurrence in patients with gastric cancer undergoing radical resection with an inadequate number of lymph nodes examined. 101 ...
2009 NOV 30 ... epithelial cells has been postulated as one of the key mechanisms in the development of gastric cancer. AID is overexpressed in the cells through nuclear factor (NF)-kappaB activation by H. ...
2009 NOV 30 ... of different forms of malignancy inducing mutations and various diseases such as gastric cancer. Biopsies and surgical samples from 53 patients (male/female 22/31, mean age 56.5 +/- ...
2009 NOV 30 ... metabolic disorders related to it have become a serious problem in Asia. Furthermore, gastric cancer in Asia is one of the frequent diseases on which to perform treatments." ...
2009 NOV 30 ... aim of this study was to clarify the ERas expression and its epigenetic regulation in gastric cancer of somatic phase. Fifteen gastric cancer cell lines ...
2009 NOV 30 ... A new study, 'Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early...
2009 NOV 30 ... of Experimental & Clinical Cancer Research (Mining novel biomarkers for prognosis of gastric cancer with serum proteomics. Journal of Experimental & Clinical Cancer Research, ...
2009 NOV 30 ... City:Changsha, Country:People's Republic of China, Adenocarcinoma, Digestive Diseases, Gastric Cancer, Gastric Carcinoma, Gastroenterology, Oncology This article was prepared by ...
2009 NOV 30 ... was to evaluate the role of re-resection in patients with local-regional recurrences of gastric cancer. and study design. Between 1998 and 2007, 26 patients underwent laparotomy for ...
2009 NOV 30 ... activity and toxicity in Chinese patients with locally advanced and metastatic gastric cancer. and study design." "Treatment consisted of irinotecan, 180 mg/m(2) ...
